Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Kathleen Duffin x
Clear All Modify Search
Charvi Kanodia Edinburgh Medical School, University of Edinburgh, UK

Search for other papers by Charvi Kanodia in
Google Scholar
PubMed
Close
,
Michael P Rimmer MRC Centre for Reproductive Health, Institute of Regeneration and Repair, University of Edinburgh, UK

Search for other papers by Michael P Rimmer in
Google Scholar
PubMed
Close
,
Kathleen Duffin Biomedical Sciences, University of Edinburgh, UK

Search for other papers by Kathleen Duffin in
Google Scholar
PubMed
Close
, and
Rod T Mitchell MRC Centre for Reproductive Health, Institute of Regeneration and Repair, University of Edinburgh, UK

Search for other papers by Rod T Mitchell in
Google Scholar
PubMed
Close

Lay summary

Men and boys with cancer treated with chemotherapy are known to have reduced fertility following their treatment. This is because some chemotherapy drugs can damage the cells in the testicles that make sperm. This study found there is limited information available on the effect of one group of chemotherapy drugs, called taxanes, on testicular function and fertility. More studies are needed to aid clinicians in advising patients on how this taxane-based chemotherapy may affect their future fertility.

Open access